Latest news with #Hodgkin
Scotsman
14 hours ago
- Health
- Scotsman
Beatson Ambassadog Juno and owner Nicole set to attend Off the Beatson Track
Beatson Cancer Charity's official Ambassadog, Juno, will return to Off the Beatson Track this summer with her devoted owner Nicole Lowther – bringing warmth, resilience, and plenty of wagging tails to the yellow streets of Glasgow on Sunday, August 24. Sign up to our daily newsletter – Regular news stories and round-ups from around Scotland direct to your inbox Sign up Thank you for signing up! Did you know with a Digital Subscription to The Scotsman, you can get unlimited access to the website including our premium content, as well as benefiting from fewer ads, loyalty rewards and much more. Learn More Sorry, there seem to be some issues. Please try again later. Submitting... Nicole, now 24, was first diagnosed with Stage 3 Hodgkin lymphoma at just 17 years old. After a stem cell transplant last year, she is now undergoing chemotherapy and immunotherapy following a relapse with Stage 4 Hodgkin lymphoma in May 2025. Despite this, Nicole remains determined to support the cause that's stood by her and her family since the very beginning. 'Off the Beatson Track is such a monumental event for me,' Nicole said. 'It's where people gather to feel included, feel love, and feel hope. It's something really special.' Nicole Lowther, Juno, Team Beatson and Bella Beatson Last year, Nicole, from Milton of Campsie, completed the 10k just six months post-transplant, walking with her closest friends and family – including her six-year-old nephew and beloved dog Juno, who went on to be crowned Beatson Cancer Charity's official Ambassadog. Juno has provided constant comfort during Nicole's treatment and recovery and continues to be a source of love and calm when it's needed most. 'Juno has been the best support for me,' Nicole shares. 'She's been by my side through it all. When my partner gets home from work, we love nothing more than to cuddle on the couch, all three of us, and thank our lucky stars for still being here.' Nicole hopes to take part in the walk again this year, but even if she isn't able to complete the route, she'll be at the start line with Juno, cheering on walkers and soaking up the uplifting atmosphere. Now in its 12th year, Off the Beatson Track has welcomed more than 20,000 participants, who have walked over 124,000 miles – turning Glasgow's west end yellow in support of people facing cancer. Nicole Lowther and Juno The 10k route begins at the Riverside Museum, heading past The Beatson West of Scotland Cancer Centre on Great Western Road, through Kelvingrove Museum, and returning to finish at the Riverside. Once across the finish line, walkers are encouraged to enjoy the festival village, with live entertainment and food stalls for all ages. Proudly sponsored by Allied Vehicles, this fun-filled day is fully accessible and suitable for everyone, with music, family entertainment, and a feel-good atmosphere throughout. Maisie McCormick, Community Fundraising Manager at Beatson Cancer Charity, said: 'We're delighted to be celebrating our 12th Off the Beatson Track event this year. We're so grateful to everyone who has taken part over the years – some families have been with us since the beginning, so we hope everyone will get behind the celebrations this year and join us. Every single person who signs up is allowing us to support more cancer patients and their families over the years to come, and we cannot thank you enough for that.' Hosted by STV's Laura Boyd and Heart Scotland's David Farrell, this year's Off the Beatson Track promises to be the biggest and brightest yet. Off the Beatson Track takes place on Sunday, August 24 and is open to people of all ages and abilities.
Time of India
20-07-2025
- Business
- Time of India
Zydus Life's plans for cancer biosimilar hit a legal hurdle
Tired of too many ads? Remove Ads Tired of too many ads? Remove Ads Mumbai: The Delhi High Court has issued an interim injunction against Ahmedabad-based drug maker Zydus Lifesciences after a case filed by the US pharma giant Bristol Myers Squibb alleging patent infringement on its blockbuster anticancer drug Opdyta nivolumab ) branded as Opdivo in other restraining order comes as a setback for the Indian drug maker which was running clinical trials in India for the launch of the biosimilar versions of nivolumab. The earliest patent for the drug expires in India on May 2, 2026. The next hearing for the case is August 101-page order issued on July 18 by Justice Mini Pushkarna ruled that the defendants, and all others acting on its behalf, are restrained from manufacturing, using, selling, offering for sale, importing, exporting, advertising, or dealing in any biosimilar/similar biologic of nivolumab, the suit patent, during the pendency of the present suit. The order stated the plaintiffs shall suffer irreparable loss, in case the interim relief as prayed for, was not injections are one of the many latest generation immunotherapy drugs also known as checkpoint inhibitors increasingly used to treat several types of cancers including skin, lungs, kidneys, and Hodgkin lymphoma. It works by activating the body's T-cells or immune cells by targeting a protein called PD-1, thereby unleashing an attack on the cancer vials are sold in India for roughly '2 lakh but for patients who are part of the company's assistance or access programs, the drug is available at a slab-wise discounted the India data is not available, globally Bristol Myers Squibb recorded Opdivo sales of $9.3 billion in 2024. Indian companies have launched biosimilars at half the cost of those charged by their global in Indian patent laws told ET that the court has taken a view that stockpiling of a product during its active patent life amounts to infringement and to release it or flood the market is not legally valid."This opinion may have implications for the other ongoing disputes like the weight-loss drug semaglutide (branded Wegovy) case between Novo Nordisk and Dr. Reddy's Labs or Roche versus Natco for Risdiplam (drug used for a rare disease called spinal muscular atrophy or SMA) case," a senior lawyer petition from BMS noted that Zydus Lifesciences was conducting clinical trials for nivolumab and on its investigation found that the company had plans to launch it during the patent period. The Indian company, it said, had applied for a marketing approval with the central drug regulatory its part, lawyers on behalf of Zydus defended saying its product ZRC-3276 does not infringe upon the existing patents and is following the regulatory was represented by a battery of top lawyers including Harish Salve, Dushyant Dave, and Rajiv Nayar, while Squibb & Sons was represented by Sandeep Sethi, PS Raman, Amit Sibal and Pravin Anand, among others.
Daily Mirror
11-07-2025
- Health
- Daily Mirror
'Doctors thought my rash was eczema - then I was told I had six months to live'
When Rachel Evans developed a rash that made her feel as though she had 'insects crawling all over her body', doctors reassured her it was just eczema. Then she received a devastating diagnosis After developing an "intense" rash across her body, Rachel Evans was told by doctors that she had eczema, but she couldn't shake the feeling that something far more serious was going on. The 46-year-old was plagued by extreme itching, dizzy spells, nosebleeds, debilitating fatigue and unexplained weight loss, and despite pushing for answers, she was repeatedly turned away. Rachel recalled: "I couldn't manage my symptoms at all. The rash was unmanageable; it felt like there were insects crawling all over my body. I couldn't cope with the intense itchiness of that rash. I couldn't sleep, and I couldn't work. It completely took over my day and night, and the fatigue I felt was intense." Her symptoms started in 2020, but it took nearly two years for doctors to send Rachel for a chest X-ray, which detected a shadow on her lungs. A CT scan and biopsy followed, and, to her horror, Rachel was diagnosed with Stage 4 Hodgkin lymphoma. Without treatment, doctors warned she may only have six months to live. READ MORE: 'I was told I had heatstroke from Turkey holiday - reality was scary' Married mum Rachel was devastated by the news, and says this was made even more difficult on account of her struggles with undiagnosed ADHD. Rachel, of Almondsbury, South Gloucestershire, shared: "Before my diagnosis, I was so burnt-out from struggling with life and undiagnosed ADHD. I have two words for how I was feeling: survival mode. "My doctors thought I would only have six months to live if I didn't have treatment. As I was emotionally dysregulated, I considered allowing my body to die from the cancer naturally. "But then I was able to consider the needs of my son, and so I decided to take the six months of ABVD chemotherapy." She added: "Everything happened really quickly. It was a very traumatic experience, more trauma on top of lifelong physical and emotional trauma caused by the ADHD. This developed into complex post-traumatic distress after chemotherapy." According to Rachel, who has a 10-year-old son and a nearly 20-year-old stepdaughter, her cancer treatment had a profound impact on her and her family. This was further compounded by the sudden illness and death of her mother-in-law. Her husband went to be with his mother in her final days, and then spent time grieving with his father and sister. Meanwhile, Rachel was left to care for her son alone for several weeks, amid a myriad of escalating challenges. Rachel explained: "Our home life was already emotionally challenged due to my undiagnosed ADHD, and our son's undiagnosed ASD and ADHD, so the cancer treatment caused a massive nosedive in the atmosphere. "In addition to the physical and emotional suffering from chemotherapy, like the pain of the picc line going in, problems with them extracting blood, panic attacks before chemo sessions, excruciatingly painful haemorrhoids, bloating, tummy pain, weight gain, loss of taste, nausea and receding gums, we had to deal with the very sudden family bereavement." In March 2023, Rachel went into remission, and while she still struggles with climbing stairs or hills, she's thankfully feeling much stronger physically. However, emotional recovery has proven to be more complicated. Rachel revealed: "My mental health has taken three years to recover. Thanks to ADHD medication, HRT for perimenopausal symptoms, psychotherapy, self-educating, and finding therapy myself, I am fully ready to engage with the world again, not just restored, but transformed." Going forward, Rachel hopes her story will help raise awareness of the more "sneaky" symptoms of Hodgkin lymphoma. She said, "I wish that more health care professionals knew more about the symptoms - blood cancer is sneaky, and it hides in the shadows. "I had a movable, painless lymph node, but not in my neck like most people get, it was in my jaw. This is uncommon, but not unknown. "My weight loss was subtle because I was already quite slender, and the weight had dropped off gradually throughout the years. "I had a history of eczema, and a history of depression and anxiety, and I think this history masked the root causes of the blood cancer and the ADHD." Rachel says her ADHD only added to the significant challenges of her diagnosis and subsequent recovery. She continued: "I don't want any other human being to struggle the way I did, either physically, emotionally, or both. "I especially have a heart for women who have undiagnosed or diagnosed ADHD, and are perimenopausal, and have had to face a cancer diagnosis on top. ADHD is subtle and not easily detected, especially in women, unless you do the detective work. "I want to raise awareness so that others are educated and have a better chance of enjoying life, in all its fullness. I believe my life was saved in many ways, for many reasons, and sharing my story is just one of them."
Irish Independent
28-06-2025
- Entertainment
- Irish Independent
'He got bored of work, and made some bad choices' – Jared Harris on his father Richard's legacy
Actor Richard Harris's archive of career memorabilia and personal items will go on show for the first time in his hometown of Limerick next month. Here, his son talks about his father's career highs and lows, his relationship with his children, and with alcohol, and why he played the fame game When the Limerick-born actor Richard Harris was in hospital being treated for advanced Hodgkin's lymphoma in 2002, he began writing his autobiography. It probably goes without saying that it would have made a hell of a read, for he was a man who had lived several lives, each one more colourful than the last. 'Unfortunately, there was some notepad [that he was writing in] that was wrapped up in all these newspapers, and one of the nurses came in and chucked the newspapers away,' Jared Harris, Richard's son, recalls. 'He was going to start again though, but… yeah. I think he definitely had an appetite for more [living].'
Irish Independent
28-06-2025
- Entertainment
- Irish Independent
‘'Hellraiser' was a story he himself fed to the press' – Jared Harris on his father Richard's legacy
Actor Richard Harris's archive of career memorabilia and personal items will go on show for the first time in his hometown of Limerick next month. Here, his son talks about his father's career highs and lows, his relationship with his children, and with alcohol, and why he played the fame game When the Limerick-born actor Richard Harris was in hospital being treated for advanced Hodgkin's lymphoma in 2002, he began writing his autobiography. It probably goes without saying that it would have made a hell of a read, for he was a man who had lived several lives, each one more colourful than the last. 'Unfortunately, there was some notepad [that he was writing in] that was wrapped up in all these newspapers, and one of the nurses came in and chucked the newspapers away,' Jared Harris, Richard's son, recalls. 'He was going to start again though, but… yeah. I think he definitely had an appetite for more [living].'
